{"id":3118,"date":"2023-01-02T15:38:24","date_gmt":"2023-01-02T13:38:24","guid":{"rendered":"https:\/\/eureco-pharma.nl\/portfolio\/bortezomib-25mg-ml-oplossing-voor-injectie-14ml\/"},"modified":"2023-08-22T11:53:24","modified_gmt":"2023-08-22T09:53:24","slug":"bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml","status":"publish","type":"portfolio","link":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/","title":{"rendered":"Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;7&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;445786&#8243;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;760330&#8243;][vc_custom_heading text_color=&#8221;accent&#8221; text_weight=&#8221;600&#8243; text_height=&#8221;fontheight-250781&#8243; uncode_shortcode_id=&#8221;188786&#8243; text_color_type=&#8221;uncode-palette&#8221;]Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-351981&#8243; heading_semantic=&#8221;h6&#8243; text_size=&#8221;h6&#8243; text_weight=&#8221;500&#8243; text_height=&#8221;fontheight-125243&#8243; uncode_shortcode_id=&#8221;167446&#8243; text_color_type=&#8221;uncode-palette&#8221;]Oncolytics[\/vc_custom_heading][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; inverted_device_order=&#8221;yes&#8221; uncode_shortcode_id=&#8221;180068&#8243; css=&#8221;.vc_custom_1670255150844{margin-top: 10px !important;}&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;3\/4&#8243; uncode_shortcode_id=&#8221;139983&#8243;][vc_column_text uncode_shortcode_id=&#8221;752182&#8243;]Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.<\/p>\n<p>Bortezomib EVER Pharma is used to treat multiple myeloma, a type of cancer that affects the bone marrow, in patients aged 18 years and older. It is also used for the treatment of mantle cell lymphoma, a form of cancer that affects the lymph nodes. It is combined with the drugs rituximab, cyclophosphamide, doxorubicin, and prednisone in patients aged 18 years or older who have not received previous treatment and are not suitable for blood stem cell transplantation.<\/p>\n<p>A detailed description of the effectiveness and possible side effects of this medication can be found in the patient package leaflet and summary of product characteristics.[\/vc_column_text][vc_empty_space empty_h=&#8221;1&#8243;][vc_button button_color=&#8221;accent&#8221; radius=&#8221;btn-circle&#8221; hover_fx=&#8221;full-colored&#8221; border_width=&#8221;0&#8243; link=&#8221;url:http%3A%2F%2Feureco-pharma.nl%2Fwp-content%2Fuploads%2F2023%2F01%2Fh127130_smpc.pdf|target:_blank&#8221; button_color_type=&#8221;uncode-palette&#8221; uncode_shortcode_id=&#8221;305959&#8243; el_class=&#8221;ep-smpc-btn&#8221;]SmPc[\/vc_button][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_single_image dynamic=&#8221;yes&#8221; media_width_use_pixel=&#8221;yes&#8221; uncode_shortcode_id=&#8221;777805&#8243; media_width_pixel=&#8221;100&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][uncode_block id=&#8221;3060&#8243;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][uncode_block id=&#8221;3016&#8243;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][uncode_block id=&#8221;3036&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor. <\/p>\n","protected":false},"author":1,"featured_media":2753,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"portfolio_category":[57],"class_list":["post-3118","portfolio","type-portfolio","status-publish","has-post-thumbnail","hentry","portfolio_category-oncolytics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml - Eureco-Pharma<\/title>\n<meta name=\"description\" content=\"Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml - Eureco-Pharma\" \/>\n<meta property=\"og:description\" content=\"Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/\" \/>\n<meta property=\"og:site_name\" content=\"Eureco-Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-22T09:53:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/\",\"url\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/\",\"name\":\"Bortezomib solution for injection 2.5mg\\\/ml vial | 1.4ml - Eureco-Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eureco-pharma.nl\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/oplossing-voor-injectie.svg\",\"datePublished\":\"2023-01-02T13:38:24+00:00\",\"dateModified\":\"2023-08-22T09:53:24+00:00\",\"description\":\"Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eureco-pharma.nl\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/oplossing-voor-injectie.svg\",\"contentUrl\":\"https:\\\/\\\/eureco-pharma.nl\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/oplossing-voor-injectie.svg\",\"width\":\"200\",\"height\":\"200\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portfolio\",\"item\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/portfolio\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bortezomib solution for injection 2.5mg\\\/ml vial | 1.4ml\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/\",\"name\":\"Eureco-Pharma\",\"description\":\"Part of the Solution\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eureco-pharma.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml - Eureco-Pharma","description":"Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/","og_locale":"en_US","og_type":"article","og_title":"Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml - Eureco-Pharma","og_description":"Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.","og_url":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/","og_site_name":"Eureco-Pharma","article_modified_time":"2023-08-22T09:53:24+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/","url":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/","name":"Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml - Eureco-Pharma","isPartOf":{"@id":"https:\/\/eureco-pharma.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/#primaryimage"},"image":{"@id":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/#primaryimage"},"thumbnailUrl":"https:\/\/eureco-pharma.nl\/wp-content\/uploads\/2022\/09\/oplossing-voor-injectie.svg","datePublished":"2023-01-02T13:38:24+00:00","dateModified":"2023-08-22T09:53:24+00:00","description":"Bortezomib EVER Pharma is a medication used in the treatment of cancer. It contains the active ingredient bortezomib, which is a proteasome inhibitor.","breadcrumb":{"@id":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/#primaryimage","url":"https:\/\/eureco-pharma.nl\/wp-content\/uploads\/2022\/09\/oplossing-voor-injectie.svg","contentUrl":"https:\/\/eureco-pharma.nl\/wp-content\/uploads\/2022\/09\/oplossing-voor-injectie.svg","width":"200","height":"200"},{"@type":"BreadcrumbList","@id":"https:\/\/eureco-pharma.nl\/en\/portfolio\/bortezomib-2-5mg-ml-solution-for-injection-vial-1-4ml\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eureco-pharma.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Portfolio","item":"https:\/\/eureco-pharma.nl\/en\/portfolio\/"},{"@type":"ListItem","position":3,"name":"Bortezomib solution for injection 2.5mg\/ml vial | 1.4ml"}]},{"@type":"WebSite","@id":"https:\/\/eureco-pharma.nl\/en\/#website","url":"https:\/\/eureco-pharma.nl\/en\/","name":"Eureco-Pharma","description":"Part of the Solution","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eureco-pharma.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/portfolio\/3118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/types\/portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/comments?post=3118"}],"version-history":[{"count":5,"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/portfolio\/3118\/revisions"}],"predecessor-version":[{"id":3880,"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/portfolio\/3118\/revisions\/3880"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/media\/2753"}],"wp:attachment":[{"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/media?parent=3118"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/eureco-pharma.nl\/en\/wp-json\/wp\/v2\/portfolio_category?post=3118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}